Minireviews
Copyright ©The Author(s) 2022.
World J Stem Cells. May 26, 2022; 14(5): 318-329
Published online May 26, 2022. doi: 10.4252/wjsc.v14.i5.318
Table 1 Preclinical studies of mesenchymal stem cell-exosomes in cutaneous wound healing phases
Wound healing phase
Exosome cellular origin
Model
Functional effects
Pathways
Ref.
InflammationhBMMSCs; hJMMSCsMice dorsal skin defectsMacrophage M2 polarizationmiR-223 via pknox1[38]
hUCMSCsRat severe burnM2 polarization. Inflammation alleviationmiR-181c via TLR4[39]
LPS-pretreated hUCMSCsRat diabetic cutaneous woundM2 polarizationLet-7b via TLR4/NF-κB/STAT3/AKT[40]
mBMMSCsMice skin excision woundPromote beneficial regulatory T cell responses and M2 polarizationM2/Th2/Treg responses[44]
ProliferationhADMSCsMice full-thickness incision woundPromote fibroblast proliferation and migration; optimize collagen depositionPI3K/Akt[47]
hUCMSCsRat skin burnEnhance re-epithelialization and cell proliferation; reduce heat stress-induced apoptosisWnt/β-catenin; AKT[51]
hiPSC-MSCsRat dorsal skin woundAccelerate skin cell proliferation and migration; promote collagen synthesis and angiogenesisERK1/2[52,53]
RemodelinghADMSCsMice skin incisional woundMitigating scar formation; promote ECM reconstructionERK/MAPK[55]
hUCMSCsMice full-thickness skin defectsSuppress myofibroblast differentiation and scar formationTGF-β/SMAD2[56,57]
hAFSCsRat full-thickness skin woundAnti-fibrotic scarring; suppress the excessive aggregation of myofibroblasts and ECMTGF-β[58]